home / stock / tars / tars quote
Last: | $36.85 |
---|---|
Change Percent: | -3.23% |
Open: | $35.75 |
Close: | $36.85 |
High: | $37.14 |
Low: | $35.51 |
Volume: | 684,003 |
Last Trade Date Time: | 05/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$36.85 | $35.75 | $36.85 | $37.14 | $35.51 | 684,003 | 05-03-2024 |
$34.63 | $32.31 | $34.63 | $34.63 | $32.02 | 446,461 | 05-02-2024 |
$32.49 | $31.36 | $32.49 | $33.489 | $30.71 | 712,016 | 05-01-2024 |
$31.43 | $31.51 | $31.43 | $32 | $30.225 | 581,667 | 04-30-2024 |
$32.12 | $32.31 | $32.12 | $33.1929 | $31.83 | 453,654 | 04-29-2024 |
$32.04 | $32.57 | $32.04 | $33.21 | $31.26 | 381,058 | 04-26-2024 |
$32.21 | $31.85 | $32.21 | $32.62 | $31.49 | 371,846 | 04-25-2024 |
$32.76 | $33.98 | $32.76 | $34.35 | $32.41 | 317,495 | 04-24-2024 |
$33.71 | $32.14 | $33.71 | $34.11 | $32.14 | 219,423 | 04-23-2024 |
$32.29 | $33.04 | $32.29 | $33.25 | $31.88 | 288,215 | 04-22-2024 |
$32.44 | $32.44 | $32.44 | $33.69 | $31.72 | 657,454 | 04-19-2024 |
$32.85 | $33.97 | $32.85 | $34.545 | $32.81 | 317,828 | 04-18-2024 |
$34.42 | $35.11 | $34.42 | $35.11 | $33.91 | 325,658 | 04-17-2024 |
$34.9 | $34.5 | $34.9 | $36.565 | $34.42 | 459,292 | 04-16-2024 |
$34.94 | $36.25 | $34.94 | $36.73 | $34.75 | 328,128 | 04-15-2024 |
$36.17 | $38.23 | $36.17 | $38.335 | $35.02 | 392,011 | 04-12-2024 |
$38.29 | $35.89 | $38.29 | $38.46 | $35.55 | 931,851 | 04-11-2024 |
$35.88 | $35.31 | $35.88 | $36.475 | $35.12 | 710,504 | 04-10-2024 |
$36.26 | $35.6 | $36.26 | $36.52 | $34.6732 | 865,116 | 04-09-2024 |
$35.21 | $35.03 | $35.21 | $35.545 | $34.4762 | 463,783 | 04-08-2024 |
News, Short Squeeze, Breakout and More Instantly...
Tarsus Pharmaceuticals Inc. Company Name:
TARS Stock Symbol:
NASDAQ Market:
IRVINE, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS), whose mission is to focus on unmet needs and apply ...
IRVINE, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced that it will host a live webcast at 1...
IRVINE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced that it has secured $200 million in...